Since October the National Institutes of Health have spent or set aside about $25 million for projects like Armstrong‘s that take a targeted approach to developing drugs against AIDS. Most extramural funding for the program—about $13 million—comes from grants administered jointly by the National Cancer Institute and the National Institute of Allergies and Infectious Diseases. It is part of the $252 million that NIH will spend this year on AIDS research.
An additional $10 million, awarded from the director‘s office at NIH, has been divided equally between extramural and intramural research. Applications for the $5 million in extramural funds are being accepted through March 23 by the National Institute of General Medical Sciences for studies of viral structure; the intramural awards are meant to enlist the help of X-ray crystallographers, spectroscopists and other NIH researchers not ordinarily involved in AIDS research.
Advances in molecular biology and in imaging techniques, including ...
